Está aquí: Home > Therapeutics (antiguo) > Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment

J Cannabis Ther 2001(2):21-92

Headache

Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment

Author
E. Russo

Abstract
Cannabis, or ''marijuana,'' has been employed in various forms throughout the millennia for both symptomatic and prophylactic treatment of migraine. This document examines its history of medicinal use by smoking and other methods in ancient cultures, including the Chinese, Indian, Egyptian, Assyrian, Greek and Roman, as well as in the Islamic world, and its subsequent adoption by Renaissance and Industrial Age Europeans.

The most prominent physicians of the age in the century between 1842 and 1942 preferred cannabis to other preparations in migraine treatment, and it remained part of Western pharmacopoeias for this indication throughout the period. The writings of this era are examined in great detail in an effort to emphasize useful medical documentation that has subsequently been forgotten.

In modern times, ethnobotanical and anecdotal references continue to support the efficacy of cannabis for headache treatment, while biochemical studies of THC and anandamide have provided scientific justification for its use via anti-inflammatory, serotonergic and dopaminergic mechanisms, as well as by interaction with NMDA and endogenous opioid systems. These are examined in detail.

The author feels that this collective evidence supports the proposition that experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.


Keywords
Migraine, headache, cannabis, marijuana, dronabinol, ethnobotany, Indian hemp, pain, analgesia, history of medicine, psychopharmacology, endocannabinoids, anandamide

Versión PDF del texto completo ]

Eventos en línea 2020

Toda la información sobre los eventos en línea de la IACM, incluidos los vídeos gratuitos de los seminarios web con subtítulos en español, puede encontrarse aquí.

Conferencia 2022

 La 12ª Conferencia de la IACM sobre Cannabinoides en Medicina se celebrará los días 20 y 21 de octubre de 2022 junto con la SSCM suiza en Basilea/Suiza.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.